Topera E-FIRM Registry
Source: ClinicalTrials.gov NCT02386345 ↗Summary
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Acute Success |
165 | — |
| PRIMARY Number of Participants With 12-Month Success |
101 | — |
| PRIMARY Number of Participants With Acute Safety Success |
257 | — |
| PRIMARY Number of Participants With 12-Month Safety Success |
184 | — |
Eligibility Criteria
Inclusion Criteria
reported incidence of at least 2 documented episodes of symptomatic AF (paroxysmal, persistent or long standing persistent) during the 3 months preceding the initial AF ablation attempt of at least one Class I or III anti-arrhythmia drug with failure defined as recurrence of symptomatic AF or adverse drug effect resulting in stopping medication
Exclusion Criteria
women who are pregnant
As this is a registry only data of patients will be included who have been treated according to the current AF guidelines.
Data sourced from ClinicalTrials.gov (NCT02386345). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.